Computer Science and Engineering

Dr. Josh Nahum primary involvement with the department has been to teach a variety of undergraduate courses including CSE 220, CSE 232, CSE 440, CSE 450, CSE 480, and many others. He enjoys cycling around Lansing and learning new programming languages. He has a German Shepard named Mal and 4 ferrets.


 

Parisa Kordjamshidi is an assistant professor in the Department of Computer Science and Engineering at Michigan State University. She holds an affiliated with Florida Institute for Human and Machine Cognition as a research scientist.  Prior to MSU, she was an assistant professor at Tulane University (2016-2019). She was a Postdoctoral researcher at University of Illinois at Urbana-Champaign (2013-2016).

Mi Zhang received his B.S. degree in Electrical Engineering from Peking University (PKU). He received his Ph.D. degree in Computer Engineering and M.S. degrees in both Electrical Engineering and Computer Science from University of Southern California (USC). Before joining MSU, he was a Postdoctoral Associate in Computing and Information Science at Cornell University

Computational optimization; optimal design; process optimization; optimal modeling and optimal system design; multi-objective optimization and multi-criterion decision analysis; large-scale optimization; evolutionary multi-objective optimization (EMO) for handling practicalities -- uncertainties, constraints, multi-modalities, noise, and mixed variables; meta-modeling in optimization; hybrid optimization algorithms using evolutionary and classical methods;  evolutionary computation in search, optimization of control of engineering problems; multi-modal optimization; design of self-adaptive

Our laboratory applies cellular, molecular engineering and systems biology approaches to investigate disease mechanisms. We are studying endoplasmic reticulum (ER) stress related diseases, in particular, we are interested in how fatty acids interact with ER transmembrane sensor proteins to drive the development of cancer metastasis and neurological diseases. Our laboratory also is developing therapeutics using engineering approaches (e.g. drug delivery systems and stem cell engineering techniques) to modulate the pathways altered in these diseases.